Evidence map›Paper›PMID 31573738›Full record

ReviewCancer medicine2019

Apolipoproteins and cancer.

Liwen Ren, Jie Yi, Wan Li, Xiangjin Zheng, Jinyi Liu, Jinhua Wang, Guanhua Du

Open access · goldAbstract readReview
In one paragraph

Review in Cancer medicine, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 97 papers.

0numbers the graph read from it
0cells of the map it votes in
97citing papers in PubMed
4.8field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

97 citing papers in PubMed, 141 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

37 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Liwen RenThe State Key Laboratory of Bioactive Substance and Function of Natural Medicines, Beijing, China.
Jie YiDepartment of Clinical Laboratory, Peking Union Medical College Hospital, Beijing, People's Republic of China.ORCID 0000-0003-1625-768X
Wan LiThe State Key Laboratory of Bioactive Substance and Function of Natural Medicines, Beijing, China.
Xiangjin ZhengThe State Key Laboratory of Bioactive Substance and Function of Natural Medicines, Beijing, China.
Jinyi LiuThe State Key Laboratory of Bioactive Substance and Function of Natural Medicines, Beijing, China.
Jinhua WangThe State Key Laboratory of Bioactive Substance and Function of Natural Medicines, Beijing, China.ORCID 0000-0001-8367-0787
Guanhua DuThe State Key Laboratory of Bioactive Substance and Function of Natural Medicines, Beijing, China.
Chinese Academy of Medical Sciences & Peking Union Medical College · CN

Funding

Beijing Natural Science Foundation 7172142CAMS Innovation Fund for Medical Sciences 2016-I2M-3-007National Natural Science Foundation of China 81573454Technology Major Projects for "Major New Drugs Innovation and Development" 2018ZX09711001-005-025
6 · The paper itself

Abstract

The role of apolipoproteins in cardiovascular disease has been well investigated, but their participation in cancer has only been explored in a few published studies which showed a close link with certain kinds of cancer. In this review, we focused on the function of different kinds of apolipoproteins in cancers, autophagy, oxidative stress, and drug resistance. The potential application of apolipoproteins as biomarkers for cancer diagnosis and prognosis was highlighted, together with an investigation of their potential as drug targets for cancer treatment. Many important roles of apolipoproteins and their mechanisms in cancers were reviewed in detail and future perspectives of apolipoprotein research were discussed.

Indexed as

AnimalsApolipoproteinsAutophagyDrug Resistance, NeoplasmHumansNeoplasmsOxidative StressApolipoproteinsapolipoproteinautophagycancerdrug resistanceoxidative stress

Identifiers

PMID31573738
PMCPMC6853823
OpenAlexW2978056808

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.